SCHEMBL3087549

SCHEMBL3087549

c1cc(N2CCC3(CCCNC3)C2)ccn1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.74
CYP2D6 P10635 8/20 0.74
ALDH1A1 P00352 7/20 0.74
CYP1A2 P05177 5/20 0.74
USP2 O75604 3/20 0.74
CYP2C19 P33261 7/20 0.67
HSD17B10 Q99714 4/20 0.67
MAPK1 P28482 3/20 0.67
HPGD P15428 2/20 0.67
TP53 P04637 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
TSHR P16473 5/20 0.65
CYP2C9 P11712 5/20 0.65
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
HIF1A Q16665 1/20 0.48
ADRB2 P07550 1/20 0.47
NCF1 P14598 1/20 0.47
PLD1 Q13393 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2817996 0.99 CYP3A4 (0.72) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
SCHEMBL11955031 0.94 CYP3A4 (0.74) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
Hydrochloric Acid SCHEMBL485450 0.93 CYP3A4 (0.72) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
SCHEMBL13050666 0.91 CYP3A4 (0.60) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
SCHEMBL2834740 0.91 CYP3A4 (0.68) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
Hydrochloric Acid SCHEMBL485785 0.90 CYP3A4 (0.67) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
SCHEMBL13131243 0.88 CYP3A4 (0.83) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
Hydrochloric Acid SCHEMBL2816934 0.87 CYP3A4 (0.81) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
SCHEMBL38664534 0.86 CYP3A4 (0.60) CYP3A4CYP2D6ALDH1A1CYP1A2USP2
Hydrochloric Acid SCHEMBL30328825 0.84 CYP3A4 (0.97) CYP3A4CYP2D6ALDH1A1CYP1A2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885ALDH1A1 2086/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885ALDH1A1 2086/4885
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B CYP3A4 1215/4885CYP2D6 950/4885ALDH1A1 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.